Phase 1b data for NC410 and further updates on other clinical programs expected in the fourth quarter of 2023 Cash of approximately $131 million expected to fund operations into mid-2025 BELTSVILLE, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel,… Read More..

he Company Will Conduct an Investor Update Call on August 9 at 10:30am EST to Discuss its Progress and Growing Sales of its Plug & Play Smart and Standard Products, Financials, as Well as its Continuing Safety Standardization Progress The Company will Provide an Access Link to the Investor Update… Read More..

DALLAS, August 02, 2023--(BUSINESS WIRE)--Blackboxstocks, Inc. (NASDAQ: BLBX) ("Blackbox"), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, today announced the launch of its Pro Tier Trading Package that will allow professional traders, financial institutions, and RIA’s to subscribe to the Blackbox… Read More..